The “neuro” of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder

A nationwide survey of opsoclonus–myoclonus syndrome in Japanese children

(2015) Shunji Hasegawa et al.   BRAIN & DEVELOPMENT

Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

(2015) Kristopher R. Bosse et al.   CANCER

Premigratory and Migratory Neural Crest Cells Are Multipotent In Vivo

(2015) Arianna Baggiolini et al.   Cell Stem Cell

Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma

(2015) L. A. Wylie et al.   Disease Models & Mechanisms

Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)

(2015) Margaret J. Zhou et al.   EUROPEAN JOURNAL OF CANCER

Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome

(2015) Jessica A. Panzer et al.   JOURNAL OF NEUROIMMUNOLOGY

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

(2015) Thomas F Eleveld et al.   NATURE GENETICS

A distinct gene expression signature characterizes human neuroblastoma cancer stem cells

(2015) Robert A. Ross et al.   Stem Cell Research

Schwann Cells: Development and Role in Nerve Repair

(2015) Kristján R. Jessen et al.   Cold Spring Harbor Perspectives in Biology

The Genetics of Splicing in Neuroblastoma

(2015) J. Chen et al.   Cancer Discovery

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2immunotherapy and isotretinoin: a prospective Phase II study

(2015) Brian H Kushner et al.   OncoImmunology

Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis

(2015) Bret C. Mobley et al.   PLoS One

Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells

(2015) Kristian W. Pajtler et al.   Oncotarget

Cerebellar and cortical abnormalities in paediatric opsoclonus-myoclonus syndrome

(2014) Geetha Anand et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Neuroblastoma models for insights into tumorigenesis and new therapies

(2014) Shinichi Kiyonari et al.   Expert Opinion on Drug Discovery

Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS)

(2014) Wendy G. Mitchell et al.   JOURNAL OF CHILD NEUROLOGY

Mechanisms of neuroblastoma regression

(2014) Garrett M. Brodeur et al.   Nature Reviews Clinical Oncology

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

(2014) R. C. Dale et al.   NEUROLOGY

Dexmedetomidine and hydromorphone: A novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children

(2014) Matthias Görges et al.   PEDIATRIC BLOOD & CANCER

Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome

(2013) M. R. Pranzatelli et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model

(2013) Danny A. Rogers et al.   EXPERIMENTAL CELL RESEARCH

Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy

(2013) Mahiuddin Ahmed et al.   FEBS LETTERS

Aiming at Neuroblastoma and Hitting Other Worthy Targets

(2013) Nina F. Schor   JOURNAL OF CHILD NEUROLOGY

CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids

(2013) Michael R. Pranzatelli et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Dependence receptor UNC5D mediates nerve growth factor depletion–induced neuroblastoma regression

(2013) Yuyan Zhu et al.   JOURNAL OF CLINICAL INVESTIGATION

Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity

(2013) Lizzia Raffaghello et al.   JOURNAL OF LEUKOCYTE BIOLOGY

CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders

(2013) Michael R. Pranzatelli et al.   JOURNAL OF NEUROIMMUNOLOGY

BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

(2013) Michael R Pranzatelli et al.   Journal of Neuroinflammation

The genetic landscape of high-risk neuroblastoma

(2013) Trevor J Pugh et al.   NATURE GENETICS

Neuroblastoma and MYCN

(2013) M. Huang et al.   Cold Spring Harbor Perspectives in Medicine

Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome

(2012) Elizabeth D. Tate et al.   JOURNAL OF CHILD NEUROLOGY

The Dorsal Aorta Initiates a Molecular Cascade That Instructs Sympatho-Adrenal Specification

(2012) D. Saito et al.   SCIENCE

Long-term Follow-up of the “Wait and See” Approach to Localized Perinatal Adrenal Neuroblastoma

(2012) Denis Andrew Cozzi et al.   WORLD JOURNAL OF SURGERY

Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome

(2011) Andreas Brunklaus et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings

(2011) Anneleen Decock et al.   Epigenetics

Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus

(2011) Michael R. Pranzatelli et al.   PEDIATRIC BLOOD & CANCER

Cerebrospinal Fluid Oligoclonal Bands in Childhood Opsoclonus-Myoclonus

(2011) Michael R. Pranzatelli et al.   PEDIATRIC NEUROLOGY

Outcome and Prognostic Features in Opsoclonus-Myoclonus Syndrome From Infancy to Adult Life

(2011) A. Brunklaus et al.   PEDIATRICS

NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome

(2010) Michael Hölzel et al.   CELL

On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology

(2009) C. J. Thiele et al.   CLINICAL CANCER RESEARCH

Trk Receptor Expression and Inhibition in Neuroblastomas

(2009) G. M. Brodeur et al.   CLINICAL CANCER RESEARCH

Insights on Chronic-Relapsing Opsoclonus-Myoclonus From a Pilot Study of Mycophenolate Mofetil

(2009) Michael R. Pranzatelli et al.   JOURNAL OF CHILD NEUROLOGY

Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy

(2008) Danny Rogers et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY